Le Lézard
Classified in: Health
Subjects: AWD, NPT, TDS

Lymphoma Research Foundation Honors Southern Glazer's Wine & Spirits with 2019 Hope Award

NEW YORK, June 13, 2019 /PRNewswire-PRWeb/ -- The Lymphoma Research Foundation (LRF) ? the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services ? presented the 2019 Hope Award to Southern Glazer's Wine & Spirits (SGWS), the world's pre-eminent distributor of beverage alcohol. The company was honored during the third installment of Swirl: Chicago on May 30 at the Casino in Chicago.

Given in recognition of corporations, businesses and individuals who have worked diligently toward the Foundation's mission of eradicating lymphoma and serving those impacted by this blood cancer, the 2019 Hope Award was presented to SGWS in appreciation of the support of LRF's Swirl: A Wine Tasting Event series, where SGWS is a Founding Sponsor. Since 2013, the Foundation has been able to expand its series from its inaugural market in Miami to five additional markets including Chicago, Dallas, Minneapolis, New York City, and Orange County, Calif. In addition, the Foundation marked a major milestone for the series, raising more than $1 million since the series' inception.

The Hope Award was presented by LRF's Chair of the Board of Directors, Michael Werner during a special award ceremony at Swirl: Chicago. LRF Board member, steadfast supporter of the Foundation's Swirl series and Executive Vice President of Commercial Operations at Southern Glazer's Wine & Spirits Kevin Fennessey accepted the award on behalf of SGWS.

"As the Founding Sponsor of the Swirl series, Southern Glazer's is incredibly inspired by the series' tremendous success and the impact our partnership has on the lymphoma community," said Kevin Fennessey, Executive Vice President of Commercial Operations at Southern Glazer's Wine & Spirits. "We look forward to our continued partnership and expanding to more communities to further our support of LRF and all those impacted by a lymphoma diagnosis."

"We are grateful for Southern Glazer's Wine & Spirits support of the Swirl: A Wine Tasting Event series," said Meghan Gutierrez, Chief Executive Officer at the Lymphoma Research Foundation. "Due to their extraordinary generosity and commitment to LRF's mission, we were able to not only raise more than $1 million but also bring together philanthropic communities around the country to make an impact on lymphoma research and the lives of people affected by this blood cancer. We are honored to show our gratitude to SGWS by presenting them with the 2019 Hope Award."

For more information about Swirl: A Wine Tasting Event, visit lymphoma.org/swirl.

About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation's largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $62 million in lymphoma-specific research. For additional information on LRF's research, education and services, visit lymphoma.org.

About Southern Glazer's Wine & Spirits
Southern Glazer's Wine & Spirits is the world's pre-eminent distributor of beverage alcohol, and proud to be a multi-generational, family-owned company. The Company has operations in 44 U.S. states and the District of Columbia, Canada, and the Caribbean, and employs more than 20,000 team members. Southern Glazer's urges all retail customers and adult consumers to market, sell, serve, and enjoy its products responsibly. For more information visit http://www.southernglazers.com. Follow us on Twitter and Instagram @sgwinespirits, and on Facebook at http://www.facebook.com/SouthernGlazers.


SOURCE Lymphoma Research Foundation

These press releases may also interest you

at 19:30
After three decades as an oncology nurse, Janet Soboleski, BSN, RN, OCN, knows that while different cancers have different symptoms and prognoses, virtually all cancer patients experience a sense of isolation. "Cancer is...

at 19:15
An article published in Experimental Biology and Medicine (Volume 244, Issue 10, July, 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219850787) reports that noninvasive imaging techniques can be used to study eye development. The study,...

at 19:13
Global Phosphoinositide 3-Kinase (PI3K) inhibitors Market: About this market Read the full report: https://www.reportlinker.com/p05797190/?utm_source=PRN Phosphoinositide 3-kinase (PI3K) inhibitors restricts PI3K enzymes and help in controlling...

at 19:12
Global Ophthalmology Devices Market: About this market Ophthalmology devices discussed in this report include both diagnostic and surgical equipment to treat glaucoma, refraction, cataract, retinal disorders, dry eye, myopia, hypermetropia, and...

at 19:12
Global Phosphodiesterase (PDE) inhibitors Market: About this marketPhosphodiesterase inhibitors represent a drug class comprising drugs with a similar mechanism of action i.e. by inhibiting PDE enzymes. This phosphodiesterase inhibitors market...

at 19:00
On May 24, 2019, RCCA MSO LLC ("RCCA MSO"), the management services entity for Regional Cancer Care Associates LLC ("RCCA") and RCCA MD LLC ("RCCA MD" and together with RCCA MSO and RCCA, the "RCCA Group") became aware of suspicious activity...

News published on 13 june 2019 at 12:00 and distributed by: